MiMedx Group Inc MDXG
News
THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES'
MIMEDX to Participate in Upcoming Investor Conferences
DEFENDANT FIGHTS BACK AGAINST MiMEDX "BLATANT INTIMIDATION" NON-COMPETE SUIT
MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix
MIMEDX Announces Second Quarter 2024 Operating and Financial Results
MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific Reports
MIMEDX to Host Second Quarter 2024 Operating and Financial Results Conference Call on July 31
Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives
MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit
Stocks to Watch: MiMedx Group, Nokia
MiMedx Group Gets FDA Warning Letter on Axiofill Classification